- Home
- INBX vs PDEX Comparison
INBX vs PDEX Comparison
Compare INBX & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- PDEX
- Stock Information
- Founded
- INBX 2010
- PDEX 1978
- Country
- INBX United States
- PDEX United States
- Employees
- INBX N/A
- PDEX N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- PDEX Medical/Dental Instruments
- Sector
- INBX Health Care
- PDEX Health Care
- Exchange
- INBX Nasdaq
- PDEX Nasdaq
- Market Cap
- INBX 178.5M
- PDEX 167.6M
- IPO Year
- INBX 2020
- PDEX N/A
- Fundamental
- Price
- INBX $21.73
- PDEX $45.03
- Analyst Decision
- INBX Hold
- PDEX Strong Buy
- Analyst Count
- INBX 1
- PDEX 1
- Target Price
- INBX N/A
- PDEX $56.00
- AVG Volume (30 Days)
- INBX 122.5K
- PDEX 71.3K
- Earning Date
- INBX 08-12-2025
- PDEX 09-04-2025
- Dividend Yield
- INBX N/A
- PDEX N/A
- EPS Growth
- INBX N/A
- PDEX 379.10
- EPS
- INBX 111.58
- PDEX 2.76
- Revenue
- INBX $200,000.00
- PDEX $64,123,999.00
- Revenue This Year
- INBX N/A
- PDEX $26.92
- Revenue Next Year
- INBX N/A
- PDEX $4.48
- P/E Ratio
- INBX $0.20
- PDEX $16.29
- Revenue Growth
- INBX N/A
- PDEX 29.65
- 52 Week Low
- INBX $10.80
- PDEX $17.34
- 52 Week High
- INBX $22.31
- PDEX $70.26
- Technical
- Relative Strength Index (RSI)
- INBX 84.22
- PDEX 50.41
- Support Level
- INBX $13.97
- PDEX $46.38
- Resistance Level
- INBX $15.25
- PDEX $49.09
- Average True Range (ATR)
- INBX 1.10
- PDEX 2.28
- MACD
- INBX 0.66
- PDEX 0.56
- Stochastic Oscillator
- INBX 95.32
- PDEX 50.82
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.